Michael Albosta

1.6k total citations · 1 hit paper
48 papers, 999 citations indexed

About

Michael Albosta is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Michael Albosta has authored 48 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 10 papers in Epidemiology. Recurrent topics in Michael Albosta's work include COVID-19 Clinical Research Studies (5 papers), Cardiac Arrest and Resuscitation (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Michael Albosta is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Cardiac Arrest and Resuscitation (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Michael Albosta collaborates with scholars based in United States, India and Pakistan. Michael Albosta's co-authors include Asim Kichloo, Farah Wani, Michael Aljadah, Shantanu Solanki, Zain El‐amir, Jagmeet P. Singh, Ashok Kumar Kanugula, Savneek Chugh, Raja Chandra Chakinala and Jesse Bakke and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Michael Albosta

47 papers receiving 969 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA

2020 481 citations Asim Kichloo, Michael Albosta et al. profile →

Peers

Countries citing papers authored by Michael Albosta

Since Specialization

Citations

This map shows the geographic impact of Michael Albosta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Albosta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Albosta more than expected).

Fields of papers citing papers by Michael Albosta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Albosta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Albosta. The network helps show where Michael Albosta may publish in the future.

Co-authorship network of co-authors of Michael Albosta

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Albosta. A scholar is included among the top collaborators of Michael Albosta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Albosta. Michael Albosta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	US trends of in-hospital morbidity and mortality for acute myocardial infarctions complicated by cardiogenic shock 2024 ·Cardiovascular revascularization medicine ·(unknown), (unknown), Michael Albosta, Jelani Grant, Jennifer Maning, Rosario Colombo	0
2	Bempedoic Acid: Lipid Lowering for Cardiovascular Disease Prevention 2023 ·Heart International ·Michael Albosta, Jelani Grant, Erin D. Michos	6
3	Cardiogenic Shock Following Acute Myocardial Infarction: Trends Of Incidence, Management, And Outcomes From The National Inpatient Sample Database Perspective 2023 ·Journal of Cardiac Failure ·(unknown), (unknown), (unknown), Rafael Hernández, Michael Albosta, (unknown), Carlos Vergara, Rosario Colombo	2
4	Outcomes of Acute Myocardial Infarction in Female Patients With Type 1 Diabetes Mellitus 2023 ·The American Journal of Cardiology ·(unknown), (unknown), Michael Albosta, Rosario Colombo	1
5	GENDER DISPARITIES IN HYPERTROPHIC CARDIOMYOPATHY FOLLOWING ALCOHOL SEPTAL ABLATION - INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE 2011-2019 2023 ·Journal of the American College of Cardiology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Albosta, Carlos E. Alfonso, Rosario Colombo	1
6	The association of racial differences with in-hospital outcomes of patients admitted for sinus node dysfunction 2022 ·Heart Rhythm O2 ·Michael Albosta, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer Maning, Jelani Grant, Rafael Hernández, Rosario Colombo	1
7	Hyperammonemia in lung transplant patients and its management: a review 2022 ·Indian Journal of Thoracic and Cardiovascular Surgery ·Akshay Kumar, Shailesh Advani, Asim Kichloo, Mohamed A. Mohamed, Farah Wani, Jagmeet Singh, Michael Albosta, (unknown), Suresh Keshavamurthy	5
8	Hospitalizations and inpatient mortality for hyperosmolar hyperglycemic state over a decade 2022 ·Diabetes Research and Clinical Practice ·Hafeez Shaka, Zain El‐amir, Farah Wani, Michael Albosta, Dushyant Singh Dahiya, (unknown), (unknown), Asim Kichloo	5
9	Outcomes of hospitalizations with acute respiratory distress syndrome with and without atrial fibrillation - Analyses from the National Inpatient Sample (2004-2014) 2022 ·The American Journal of the Medical Sciences ·Shakeel Jamal, (unknown), Abdul Mannan Khan Minhas, Asim Kichloo, Muhammad Zia Khan, Michael Albosta, Michael Aljadah, (unknown), (unknown), (unknown), (unknown), (unknown), Khalil Kanjwal	3
10	Radiation Proctitis and Management Strategies 2021 ·Clinical Endoscopy ·Dushyant Singh Dahiya, Asim Kichloo, Faiz Tuma, Michael Albosta, Farah Wani	33
11	Diabetic and Non-Diabetic Gastroparesis: A Retrospective Comparative Outcome Study From the Nationwide Inpatient Sample 2021 ·Gastroenterology Research ·Asim Kichloo, Dushyant Singh Dahiya, Farah Wani, Ehizogie Edigin, Jagmeet Singh, Michael Albosta, (unknown), Hafeez Shaka	5
12	Hyperkalemia: Major but still understudied complication among heart transplant recipients 2021 ·World Journal of Transplantation ·Jagmeet Singh, Asim Kichloo, (unknown), Michael Aljadah, Michael Albosta, Shakeel Jamal, (unknown), Sandesh Parajuli	3
13	Emerging therapeutics in the management of COVID-19 2021 ·World Journal of Virology ·Asim Kichloo, Michael Albosta, Akshay Kumar, Michael Aljadah, Mohamed Mohamed, Zain El‐amir, Farah Wani, Shakeel Jamal, Jagmeet P. Singh, (unknown)	6
14	Systemic adverse effects and toxicities associated with immunotherapy: A review 2021 ·World Journal of Clinical Oncology ·Asim Kichloo, Michael Albosta, Dushyant Singh Dahiya, (unknown), Michael Aljadah, Jagmeet Singh, Hafeez Shaka, Farah Wani, Akshay Kumar, (unknown)	59
15	Increased inpatient mortality in patients hospitalized for atrial fibrillation and atrial flutter with concomitant amyloidosis: Insight from National Inpatient Sample (NIS) 2016-2017 2021 ·Indian Pacing and Electrophysiology Journal ·Asim Kichloo, Shakeel Jamal, Michael Albosta, Muhammad Zia Khan, Michael Aljadah, Ehizogie Edigin, (unknown), Farah Wani, (unknown), Khalil Kanjwal	6
16	In-Hospital Outcomes and Prevalence of Comorbidities in Patients with St-Elevation Myocardial Infarction with and without Infective Endocarditis: Insight from the National Inpatient Sample (2013-2014) 2020 ·Journal of Investigative Medicine ·Michael Albosta, Shakeel Jamal, Asim Kichloo, Farah Wani, Beth A. Bailey, Jagmeet P. Singh, (unknown), Michael Aljadah, (unknown), (unknown), (unknown), Khalil Kanjwal	1
17	In-Hospital Outcomes and Prevalence of Comorbidities in Patients with Infective Endocarditis with and without Heart Blocks: Insight from the National Inpatient Sample 2020 ·Journal of Investigative Medicine ·Shakeel Jamal, Asim Kichloo, Michael Albosta, Beth A. Bailey, Jagmeet Singh, Farah Wani, (unknown), Muhammad Imtiaz Ahmad, (unknown), (unknown), Michael Aljadah, (unknown), (unknown), Muhammad Zia Khan	4
18	Current Immunotherapy in Gastrointestinal Malignancies a Review 2020 ·Journal of Investigative Medicine ·Dushyant Singh Dahiya, Asim Kichloo, Jagmeet Singh, Michael Albosta, (unknown)	16
19	Coexisting Cirrhosis Worsens Inpatient Outcomes in Patients With Infective Endocarditis: A Cross-Sectional Analysis of the National Inpatient Sample 2013-2014 2020 ·Cureus ·(unknown), Asim Kichloo, (unknown), Shakeel Jamal, (unknown), (unknown), Michael Albosta, Michael Aljadah, Beth A. Bailey, Jagmeet Singh, Khalil Kanjwal	1
20	COVID-19 and Hypercoagulability: A Review 2020 ·Clinical and Applied Thrombosis/Hemostasis ·Asim Kichloo, (unknown), Michael Aljadah, Michael Albosta, Shakeel Jamal, Jagmeet Singh, Farah Wani, Akshay Kumar, (unknown), Muhammad Zia Khan	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact